Neumora Therapeutics, Inc. — Investor Relations & Filings
Neumora Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to redefining neuroscience drug development. The company focuses on creating precision medicines for brain diseases, including neuropsychiatric and neurodegenerative disorders. Neumora utilizes its proprietary 'Precision Toolbox,' an integrated data science platform, to identify patient subtypes and develop targeted therapies with novel mechanisms of action. This approach aims to address the significant unmet medical needs in brain health by applying the principles of precision medicine. The company's pipeline includes navacaprant, a clinical-stage candidate for the treatment of Major Depressive Disorder (MDD).
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-29 | English | |
| 8-K - Neumora Therapeutics, Inc. (0001885522) (Filer) | 2026-05-07 | English | |
| S-8 - Neumora Therapeutics, Inc. (0001885522) (Filer) | 2026-03-30 | English | |
| 10-K - Neumora Therapeutics, Inc. (0001885522) (Filer) | 2026-03-30 | English | |
| 8-K - Neumora Therapeutics, Inc. (0001885522) (Filer) | 2026-03-30 | English | |
| 4 - NEUMORA THERAPEUTICS, INC. (0001885522) (Filer) | 2026-02-19 | English |
Browse filings by year
6 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Biocon Ltd.
Develops biosimilars and novel biologics for diabetes, onco…
|
BIOCON | IN | Manufacturing |
|
BIOCRYST PHARMACEUTICALS INC
Develops novel medicines for patients with rare and serious…
|
BCRX | US | Manufacturing |
|
Biocure Technology Inc.
Develops and commercializes advanced biological medicines, …
|
CURE.X | CA | Manufacturing |
|
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Develops novel antibody-based drugs and provides integrated…
|
2315 | HK | Manufacturing |
|
Biodexa Pharmaceuticals Plc
Clinical-stage biopharma developing treatments for rare dis…
|
BDRX | GB | Manufacturing |
|
BioDlink International Company Limited
Integrated biopharmaceutical CDMO specializing in ADC platf…
|
1875 | HK | Manufacturing |
|
BioEnvelop Technologies Corporation
Developed rapidly dissolving edible film strips for nutrace…
|
BIE | CA | Manufacturing |
|
Biofarm S.A.
A pharmaceutical company that manufactures and markets medi…
|
BIO | RO | Manufacturing |
|
BIO-FD&C CO.,LTD.
Develops active ingredients for cosmetics and pharma using …
|
251120 | KR | Manufacturing |
|
Biofil Chemicals & Pharmaceuticals
Produces pharmaceutical formulations, bulk drugs, and plast…
|
BIOFILCHEM | IN | Manufacturing |
Neumora Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33366/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33366 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33366 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33366 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33366}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Neumora Therapeutics, Inc. (id: 33366)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.